{
  "metadata": {
    "corp_code": "00427483",
    "corp_name": "대웅제약",
    "stock_code": "069620",
    "year_quarter": "2025_Q2",
    "collection_date": "2025-09-29T12:33:32.804775",
    "successful_apis": 28
  },
  "api_data": {
    "api_01": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "isu_dcrs_de": "-",
        "isu_dcrs_stle": "-",
        "isu_dcrs_stock_knd": "-",
        "isu_dcrs_qy": "-",
        "isu_dcrs_mstvdv_fval_amount": "-",
        "isu_dcrs_mstvdv_amount": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_02": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "주당액면가액(원)",
        "thstrm": "2,500",
        "frmtrm": "2,500",
        "lwfr": "2,500",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "(연결)당기순이익(백만원)",
        "thstrm": "59,650",
        "frmtrm": "24,735",
        "lwfr": "121,739",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "(별도)당기순이익(백만원)",
        "thstrm": "78,115",
        "frmtrm": "43,160",
        "lwfr": "111,502",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "(연결)주당순이익(원)",
        "thstrm": "5,184",
        "frmtrm": "2,150",
        "lwfr": "10,656",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "현금배당금총액(백만원)",
        "thstrm": "-",
        "frmtrm": "6,904",
        "lwfr": "6,904",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "주식배당금총액(백만원)",
        "thstrm": "-",
        "frmtrm": "-",
        "lwfr": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "(연결)현금배당성향(%)",
        "thstrm": "-",
        "frmtrm": "27.90",
        "lwfr": "5.70",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "현금배당수익률(%)",
        "stock_knd": "보통주",
        "thstrm": "-",
        "frmtrm": "0.50",
        "lwfr": "0.50",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "현금배당수익률(%)",
        "stock_knd": "우선주",
        "thstrm": "-",
        "frmtrm": "-",
        "lwfr": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "주식배당수익률(%)",
        "stock_knd": "보통주",
        "thstrm": "-",
        "frmtrm": "-",
        "lwfr": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "주식배당수익률(%)",
        "stock_knd": "우선주",
        "thstrm": "-",
        "frmtrm": "-",
        "lwfr": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "주당 현금배당금(원)",
        "stock_knd": "보통주",
        "thstrm": "-",
        "frmtrm": "600",
        "lwfr": "600",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "주당 현금배당금(원)",
        "stock_knd": "우선주",
        "thstrm": "-",
        "frmtrm": "-",
        "lwfr": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "주당 주식배당(주)",
        "stock_knd": "보통주",
        "thstrm": "-",
        "frmtrm": "-",
        "lwfr": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "주당 주식배당(주)",
        "stock_knd": "우선주",
        "thstrm": "-",
        "frmtrm": "-",
        "lwfr": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_03": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "stock_knd": "-",
        "acqs_mth1": "-",
        "acqs_mth2": "-",
        "acqs_mth3": "-",
        "bsis_qy": "-",
        "change_qy_acqs": "-",
        "change_qy_dsps": "-",
        "change_qy_incnr": "-",
        "trmend_qy": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_04": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "stock_knd": "보통주",
        "nm": "(주)대웅",
        "relate": "최대주주",
        "bsis_posesn_stock_co": "6,058,200",
        "bsis_posesn_stock_qota_rt": "52.29",
        "trmend_posesn_stock_co": "6,058,200",
        "trmend_posesn_stock_qota_rt": "52.29",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "stock_knd": "보통주",
        "nm": "윤재승",
        "relate": "특수관계인",
        "bsis_posesn_stock_co": "0",
        "bsis_posesn_stock_qota_rt": "0.00",
        "trmend_posesn_stock_co": "9,708",
        "trmend_posesn_stock_qota_rt": "0.08",
        "rm": "상속",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "stock_knd": "보통주",
        "nm": "윤재용",
        "relate": "특수관계인",
        "bsis_posesn_stock_co": "0",
        "bsis_posesn_stock_qota_rt": "0.00",
        "trmend_posesn_stock_co": "9,709",
        "trmend_posesn_stock_qota_rt": "0.08",
        "rm": "상속",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "stock_knd": "보통주",
        "nm": "박현령",
        "relate": "특수관계인",
        "bsis_posesn_stock_co": "34,632",
        "bsis_posesn_stock_qota_rt": "0.30",
        "trmend_posesn_stock_co": "34,632",
        "trmend_posesn_stock_qota_rt": "0.30",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "stock_knd": "보통주",
        "nm": "장봉애",
        "relate": "특수관계인",
        "bsis_posesn_stock_co": "29,126",
        "bsis_posesn_stock_qota_rt": "0.25",
        "trmend_posesn_stock_co": "0",
        "trmend_posesn_stock_qota_rt": "0.00",
        "rm": "피상속",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "stock_knd": "보통주",
        "nm": "대웅재단",
        "relate": "특수관계인",
        "bsis_posesn_stock_co": "998,453",
        "bsis_posesn_stock_qota_rt": "8.62",
        "trmend_posesn_stock_co": "998,453",
        "trmend_posesn_stock_qota_rt": "8.62",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "stock_knd": "보통주",
        "nm": "이창재",
        "relate": "등기임원",
        "bsis_posesn_stock_co": "532",
        "bsis_posesn_stock_qota_rt": "0.00",
        "trmend_posesn_stock_co": "532",
        "trmend_posesn_stock_qota_rt": "0.00",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "stock_knd": "보통주",
        "nm": "계",
        "bsis_posesn_stock_co": "7,120,943",
        "bsis_posesn_stock_qota_rt": "61.46",
        "trmend_posesn_stock_co": "7,111,234",
        "trmend_posesn_stock_qota_rt": "61.37",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "stock_knd": "-",
        "nm": "계",
        "bsis_posesn_stock_co": "-",
        "bsis_posesn_stock_qota_rt": "-",
        "trmend_posesn_stock_co": "-",
        "trmend_posesn_stock_qota_rt": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_05": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "change_on": "-",
        "mxmm_shrholdr_nm": "-",
        "posesn_stock_co": "-",
        "qota_rt": "-",
        "change_cause": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_06": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "소액주주",
        "shrholdr_co": "17,948",
        "shrholdr_tot_co": "17,959",
        "shrholdr_rate": "99.94%",
        "hold_stock_co": "1,770,583",
        "stock_tot_co": "11,586,575",
        "hold_stock_rate": "15.28%",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_07": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "nm": "이창재",
        "sexdstn": "남",
        "birth_ym": "1977년 06월",
        "ofcps": "대표이사\n(의장)",
        "rgist_exctv_at": "사내이사",
        "fte_at": "상근",
        "chrg_job": "CEO",
        "main_career": "동아대학교 중문학\n㈜대웅제약 ETC본부 소장\n㈜대웅제약 마케팅본부 본부장\n㈜대웅 사내이사\n㈜대웅제약 부사장\n現)㈜대웅제약 대표이사",
        "mxmm_shrholdr_relate": "계열회사 임원",
        "hffc_pd": "2002.12~現",
        "tenure_end_on": "2027년 03월 28일",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "nm": "이승하",
        "sexdstn": "남",
        "birth_ym": "1978년 10월",
        "ofcps": "본부장",
        "rgist_exctv_at": "미등기",
        "fte_at": "상근",
        "chrg_job": "생산본부장",
        "main_career": "영남대학교 약학\n한미약품 제제기술팀장\n한국얀센 제제팀 제조관리자\n現)㈜대웅제약 생산본부 본부장",
        "mxmm_shrholdr_relate": "계열회사 임원",
        "hffc_pd": "2016.7~現",
        "tenure_end_on": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "nm": "윤준수",
        "sexdstn": "남",
        "birth_ym": "1976년 05월",
        "ofcps": "본부장",
        "rgist_exctv_at": "미등기",
        "fte_at": "상근",
        "chrg_job": "나보타사업본부장",
        "main_career": "고려대학교대학원 생화학 박사\n큐로셀 사업담당 상무\n녹십자 경영관리 부장\n現)㈜대웅제약 나보타사업본부 본부장",
        "mxmm_shrholdr_relate": "계열회사 임원",
        "hffc_pd": "2024.05~現",
        "tenure_end_on": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "nm": "백인현",
        "sexdstn": "남",
        "birth_ym": "1967년 09월",
        "ofcps": "본부장",
        "rgist_exctv_at": "미등기",
        "fte_at": "상근",
        "chrg_job": "인니사업본부장",
        "main_career": "오클라호마시티대학교 MBA\n종근당 글로벌사업 법인장\n경북바이오산업연구원 센터장\n現) ㈜대웅제약 인니사업본부 본부장",
        "mxmm_shrholdr_relate": "계열회사 임원",
        "hffc_pd": "2024.07~現",
        "tenure_end_on": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "nm": "박승영",
        "sexdstn": "남",
        "birth_ym": "1978년 07월",
        "ofcps": "본부장",
        "rgist_exctv_at": "미등기",
        "fte_at": "상근",
        "chrg_job": "ETC 로컬본부장",
        "main_career": "대구대학교 화학\n㈜대웅제약 서울1사업부장\n現) ㈜대웅제약 ETC로컬본부 본부장",
        "mxmm_shrholdr_relate": "계열회사 임원",
        "hffc_pd": "2007.12~現",
        "tenure_end_on": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "nm": "홍승서",
        "sexdstn": "남",
        "birth_ym": "1957년 09월",
        "ofcps": "본부장",
        "rgist_exctv_at": "미등기",
        "fte_at": "상근",
        "chrg_job": "BS사업본부장",
        "main_career": "서울대학교대학원 식품공학 박사\n 삼양제넥스 생명공학연구소 부소장\n 셀트리온 미국법인장, 연구부문 사장\n 셀트리온헬스케어 대표이사\n 로피바이오 대표이사\n 센트릭스바이오 부회장\n 現) ㈜대웅제약 BS사업본부 본부장",
        "mxmm_shrholdr_relate": "계열회사 임원",
        "hffc_pd": "2025.06~現",
        "tenure_end_on": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "nm": "박성수",
        "sexdstn": "남",
        "birth_ym": "1976년 02월",
        "ofcps": "대표이사",
        "rgist_exctv_at": "사내이사",
        "fte_at": "상근",
        "chrg_job": "CEO",
        "main_career": "서울대학교 약학\n서울대학교 대학원 약학 석사\n㈜대웅제약 미국지사 법인장\n㈜대웅제약 나보타사업본부장\n ㈜대웅제약 부사장\n現)㈜대웅제약 대표이사",
        "mxmm_shrholdr_relate": "임원 및\n계열회사 임원",
        "hffc_pd": "1999.12~現",
        "tenure_end_on": "2026년 03월 29일",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "nm": "박은경",
        "sexdstn": "여",
        "birth_ym": "1983년 08월",
        "ofcps": "본부장",
        "rgist_exctv_at": "사내이사",
        "fte_at": "상근",
        "chrg_job": "CH 마케팅본부장",
        "main_career": "국민대학교 정치외교학과\n대웅제약 PM1팀 팀장\n대웅제약 소화기사업팀 팀장\n대웅제약 마케팅2사업부 사업부장\n대웅제약 ETC 마케팅본부 본부장\n現)대웅제약 CH마케팅본부 본부장",
        "mxmm_shrholdr_relate": "계열회사 임원",
        "hffc_pd": "2010.1~現",
        "tenure_end_on": "2027년 03월 28일",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "nm": "조영민",
        "sexdstn": "남",
        "birth_ym": "1970년 10월",
        "ofcps": "사외이사",
        "rgist_exctv_at": "사외이사",
        "fte_at": "비상근",
        "chrg_job": "자문",
        "main_career": "서울대학교대학원 내과학 박사\n서울대학교병원 내과 임상조교수\n캐나다 브리티쉬컬럼비아대학 방문교수\n現)서울대학교 의과대학 내과 교수",
        "mxmm_shrholdr_relate": "계열회사 임원",
        "hffc_pd": "2024.3~現",
        "tenure_end_on": "2027년 03월 28일",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "nm": "권순용",
        "sexdstn": "남",
        "birth_ym": "1960년 03월",
        "ofcps": "사외이사",
        "rgist_exctv_at": "사외이사",
        "fte_at": "비상근",
        "chrg_job": "자문",
        "main_career": "가톨릭대학교 의학대학원 박사\n美 캘리포니아 UCSD 및\n미조리 세인트루이스 워싱턴대학교 (WASH U) Visiting Scholar\n여의도성모병원 정형외과 임상과장\n가톨릭대학교 정형외과 주임교수\n가톨릭대학교 여의도성모병원 의무원장\n가톨릭대학교 성바오로병원 제11대 병원장\n가톨릭대학교 은평성모병원 초대 병원장\n現)가톨릭대학교 서울성모병원 정형외과 교수",
        "mxmm_shrholdr_relate": "계열회사 임원",
        "hffc_pd": "2025.03~現",
        "tenure_end_on": "2028년 03월 26일",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "nm": "이건행",
        "sexdstn": "남",
        "birth_ym": "1961년 04월",
        "ofcps": "감사",
        "rgist_exctv_at": "감사",
        "fte_at": "비상근",
        "chrg_job": "자문",
        "main_career": "서울대학교 대학원 법학\n법무법인(유)에이펙스 대표\n現)㈜대웅제약 상근감사",
        "mxmm_shrholdr_relate": "계열회사 임원",
        "hffc_pd": "2021.3~現",
        "tenure_end_on": "2027년 03월 28일",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "nm": "윤재승",
        "sexdstn": "남",
        "birth_ym": "1962년 11월",
        "ofcps": "CVO",
        "rgist_exctv_at": "미등기",
        "fte_at": "비상근",
        "chrg_job": "CVO",
        "main_career": "서울대 공법학 졸업\n서울지검 검사\n㈜대웅제약, ㈜대웅 대표이사",
        "mxmm_shrholdr_relate": "임원 및\n계열회사 임원",
        "hffc_pd": "2022.1~現",
        "tenure_end_on": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "nm": "유창득",
        "sexdstn": "남",
        "birth_ym": "1977년 06월",
        "ofcps": "본부장",
        "rgist_exctv_at": "미등기",
        "fte_at": "상근",
        "chrg_job": "ETC 병원본부장",
        "main_career": "경기대학교 무역학\n㈜대웅제약 서울2사업부장\n現)ETC병원본부 본부장",
        "mxmm_shrholdr_relate": "계열회사 임원",
        "hffc_pd": "2003.12~現",
        "tenure_end_on": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "nm": "박형철",
        "sexdstn": "남",
        "birth_ym": "1972년 10월",
        "ofcps": "본부장",
        "rgist_exctv_at": "미등기",
        "fte_at": "상근",
        "chrg_job": "ETC 마케팅본부장",
        "main_career": "강원대학교 제어계측공학\n㈜대웅제약 ETC로컬본부 본부장\n現)㈜대웅제약 ETC마케팅본부 본부장",
        "mxmm_shrholdr_relate": "계열회사 임원",
        "hffc_pd": "2001.3~現",
        "tenure_end_on": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_08": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "sexdstn": "남",
        "fo_bbm": "-",
        "reform_bfe_emp_co_rgllbr": "-",
        "reform_bfe_emp_co_cnttk": "-",
        "reform_bfe_emp_co_etc": "-",
        "rgllbr_co": "1,121",
        "rgllbr_abacpt_labrr_co": "-",
        "cnttk_co": "17",
        "cnttk_abacpt_labrr_co": "-",
        "sm": "1,138",
        "avrg_cnwk_sdytrn": "7.3",
        "fyer_salary_totamt": "47,807,000,000",
        "jan_salary_am": "42,000,000",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "sexdstn": "여",
        "fo_bbm": "-",
        "reform_bfe_emp_co_rgllbr": "-",
        "reform_bfe_emp_co_cnttk": "-",
        "reform_bfe_emp_co_etc": "-",
        "rgllbr_co": "584",
        "rgllbr_abacpt_labrr_co": "-",
        "cnttk_co": "55",
        "cnttk_abacpt_labrr_co": "-",
        "sm": "639",
        "avrg_cnwk_sdytrn": "5.6",
        "fyer_salary_totamt": "20,373,000,000",
        "jan_salary_am": "32,000,000",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_09": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "nm": "-",
        "ofcps": "-",
        "mendng_totamt": "-",
        "mendng_totamt_ct_incls_mendng": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_10": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "nmpr": "6",
        "jan_avrg_mendng_am": "196,000,000",
        "mendng_totamt": "1,178,000,000",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_11": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "nm": "-",
        "ofcps": "-",
        "mendng_totamt": "-",
        "mendng_totamt_ct_incls_mendng": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_12": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "한올바이오파마(주)",
        "frst_acqs_de": "2015.07.30",
        "invstmnt_purps": "경영참여",
        "frst_acqs_amount": "116,111,366,000",
        "bsis_blce_qy": "16,115,745",
        "bsis_blce_qota_rt": "31.79",
        "bsis_blce_acntbk_amount": "116,111,366,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "16,115,745",
        "trmend_blce_qota_rt": "31.75",
        "trmend_blce_acntbk_amount": "116,111,366,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "213,092,944,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-1,712,106,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "Daewoong America INC.",
        "frst_acqs_de": "2009.12.30",
        "invstmnt_purps": "경영참여",
        "frst_acqs_amount": "825,005,000",
        "bsis_blce_qy": "-",
        "bsis_blce_qota_rt": "100",
        "bsis_blce_acntbk_amount": "83,287,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "-",
        "trmend_blce_qota_rt": "100",
        "trmend_blce_acntbk_amount": "83,287,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "40,756,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-5,826,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "Daewoong Pharmaceutical (India) Private Limited",
        "frst_acqs_de": "2013.02.01",
        "invstmnt_purps": "경영참여",
        "frst_acqs_amount": "550,733,000",
        "bsis_blce_qy": "-",
        "bsis_blce_qota_rt": "100",
        "bsis_blce_acntbk_amount": "550,733,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "-",
        "trmend_blce_qota_rt": "100",
        "trmend_blce_acntbk_amount": "550,733,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "2,355,633,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-368,635,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "Daewoong Pharmaceutical Japan Co., Ltd.",
        "frst_acqs_de": "2017.03.08",
        "invstmnt_purps": "경영참여",
        "frst_acqs_amount": "555,621,000",
        "bsis_blce_qy": "1,100",
        "bsis_blce_qota_rt": "100",
        "bsis_blce_acntbk_amount": "555,621,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "1,100",
        "trmend_blce_qota_rt": "100",
        "trmend_blce_acntbk_amount": "555,621,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "3,542,115,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "131,917,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "건강한삶기술창업벤처PEF",
        "frst_acqs_de": "2018.03.19",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "2,500,000,000",
        "bsis_blce_qy": "2,500,000,000",
        "bsis_blce_qota_rt": "49.50",
        "bsis_blce_acntbk_amount": "2,500,000,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "2,500,000,000",
        "trmend_blce_qota_rt": "49.50",
        "trmend_blce_acntbk_amount": "2,500,000,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "4,407,017,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-44,399,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "(주)다나아데이터",
        "frst_acqs_de": "2018.11.23",
        "invstmnt_purps": "경영참여",
        "frst_acqs_amount": "5,100,000,000",
        "bsis_blce_qy": "102,000",
        "bsis_blce_qota_rt": "100",
        "bsis_blce_acntbk_amount": "5,100,000,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "102,000",
        "trmend_blce_qota_rt": "100",
        "trmend_blce_acntbk_amount": "5,100,000,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "5,186,447,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-481,798,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "Immplacate, INC.",
        "frst_acqs_de": "2019.03.08",
        "invstmnt_purps": "공동연구추진",
        "frst_acqs_amount": "1,125,970,000",
        "bsis_blce_qy": "1,428,571",
        "bsis_blce_qota_rt": "20.00",
        "bsis_blce_acntbk_amount": "-",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "1,428,571",
        "trmend_blce_qota_rt": "20.00",
        "trmend_blce_acntbk_amount": "-",
        "recent_bsns_year_fnnr_sttus_tot_assets": "267,045,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "133,609,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "(주)아피셀테라퓨틱스(주3)",
        "frst_acqs_de": "2020.01.23",
        "invstmnt_purps": "경영참여",
        "frst_acqs_amount": "1,960,780,000",
        "bsis_blce_qy": "4,719,292",
        "bsis_blce_qota_rt": "54.64",
        "bsis_blce_acntbk_amount": "16,657,176,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "4,719,292",
        "trmend_blce_qota_rt": "54.64",
        "trmend_blce_acntbk_amount": "16,657,176,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "30,810,640,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-187,668,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "(주)아이엔테라퓨틱스",
        "frst_acqs_de": "2020.05.27",
        "invstmnt_purps": "경영참여",
        "frst_acqs_amount": "3,118,330,000",
        "bsis_blce_qy": "19,115,085",
        "bsis_blce_qota_rt": "93.91",
        "bsis_blce_acntbk_amount": "8,118,330,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "19,115,085",
        "trmend_blce_qota_rt": "93.91",
        "trmend_blce_acntbk_amount": "8,118,330,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "10,283,824,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-14,154,731,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "Daewoong Innovation Holdings, INC.",
        "frst_acqs_de": "2021.07.14",
        "invstmnt_purps": "경영참여",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "-",
        "bsis_blce_qota_rt": "100",
        "bsis_blce_acntbk_amount": "2,355,900,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "-",
        "trmend_blce_qota_rt": "100",
        "trmend_blce_acntbk_amount": "2,355,900,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "3,307,876,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-182,714,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "Evolus.INC(해외상장)",
        "frst_acqs_de": "2021.03.23",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "3,136,869",
        "bsis_blce_qota_rt": "4.93",
        "bsis_blce_acntbk_amount": "50,907,618,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-11,720,459,000",
        "trmend_blce_qy": "3,136,869",
        "trmend_blce_qota_rt": "4.87",
        "trmend_blce_acntbk_amount": "39,187,159,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "341,877,900,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-68,771,872,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "(주)힐리언스",
        "frst_acqs_de": "2006.03.30",
        "invstmnt_purps": "경영참여",
        "frst_acqs_amount": "27,310,924,000",
        "bsis_blce_qy": "2,853,300",
        "bsis_blce_qota_rt": "78.73",
        "bsis_blce_acntbk_amount": "15,620,220,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "2,853,300",
        "trmend_blce_qota_rt": "78.73",
        "trmend_blce_acntbk_amount": "15,620,220,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "31,103,744,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "296,686,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "진켐",
        "frst_acqs_de": "2000.04.01",
        "invstmnt_purps": "공동연구추진",
        "frst_acqs_amount": "559,660,000",
        "bsis_blce_qy": "41,932",
        "bsis_blce_qota_rt": "0.27",
        "bsis_blce_acntbk_amount": "177,624,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "41,932",
        "trmend_blce_qota_rt": "0.25",
        "trmend_blce_acntbk_amount": "177,624,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "38,365,013,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-9,029,042,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "바이오넷",
        "frst_acqs_de": "2001.12.22",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "1,207,646,000",
        "bsis_blce_qy": "324,480",
        "bsis_blce_qota_rt": "1.86",
        "bsis_blce_acntbk_amount": "227,136,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "324,480",
        "trmend_blce_qota_rt": "1.83",
        "trmend_blce_acntbk_amount": "227,136,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "19,644,196,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "2,098,080,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "큐컴퍼니",
        "frst_acqs_de": "2009.07.01",
        "invstmnt_purps": "공동연구추진",
        "frst_acqs_amount": "217,377,000",
        "bsis_blce_qy": "31,110",
        "bsis_blce_qota_rt": "1.24",
        "bsis_blce_acntbk_amount": "24,574,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "31,110",
        "trmend_blce_qota_rt": "1.24",
        "trmend_blce_acntbk_amount": "24,574,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "3,214,328,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-997,642,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "3D Matrix (해외상장)(주4)",
        "frst_acqs_de": "2010.09.01",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "1,362,230,000",
        "bsis_blce_qy": "320,000",
        "bsis_blce_qota_rt": "1.49",
        "bsis_blce_acntbk_amount": "493,317,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "164,721,000",
        "trmend_blce_qy": "320,000",
        "trmend_blce_qota_rt": "0.32",
        "trmend_blce_acntbk_amount": "658,038,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "65,850,990,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-25,286,861,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "카이페리온",
        "frst_acqs_de": "2019.10.16",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "1,000,020,000",
        "bsis_blce_qy": "28,572",
        "bsis_blce_qota_rt": "3.53",
        "bsis_blce_acntbk_amount": "-",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "28,572",
        "trmend_blce_qota_rt": "3.53",
        "trmend_blce_acntbk_amount": "-",
        "recent_bsns_year_fnnr_sttus_tot_assets": "2,720,169,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-511,029,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "JTBC",
        "frst_acqs_de": "2011.04.01",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "3,000,000,000",
        "bsis_blce_qy": "600,000",
        "bsis_blce_qota_rt": "0.52",
        "bsis_blce_acntbk_amount": "419,400,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "600,000",
        "trmend_blce_qota_rt": "0.52",
        "trmend_blce_acntbk_amount": "419,400,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "476,961,232,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-42,747,225,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "향남제약공단",
        "frst_acqs_de": "2005.11.10",
        "invstmnt_purps": "일반참여",
        "frst_acqs_amount": "217,879,000",
        "bsis_blce_qy": "-",
        "bsis_blce_qota_rt": "-",
        "bsis_blce_acntbk_amount": "847,017,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "-",
        "trmend_blce_qota_rt": "-",
        "trmend_blce_acntbk_amount": "847,017,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "10,028,653,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-1,351,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "자일자동차판매",
        "frst_acqs_de": "2011.12.01",
        "invstmnt_purps": "일반참여",
        "frst_acqs_amount": "827,695,000",
        "bsis_blce_qy": "93,286",
        "bsis_blce_qota_rt": "0.45",
        "bsis_blce_acntbk_amount": "-",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "93,286",
        "trmend_blce_qota_rt": "0.45",
        "trmend_blce_acntbk_amount": "-",
        "recent_bsns_year_fnnr_sttus_tot_assets": "285,044,000,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-43,064,000,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "대우산업개발",
        "frst_acqs_de": "2012.06.05",
        "invstmnt_purps": "일반참여",
        "frst_acqs_amount": "592,014,000",
        "bsis_blce_qy": "33,296",
        "bsis_blce_qota_rt": "0.43",
        "bsis_blce_acntbk_amount": "-",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "33,296",
        "trmend_blce_qota_rt": "0.43",
        "trmend_blce_acntbk_amount": "-",
        "recent_bsns_year_fnnr_sttus_tot_assets": "114,381,873,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-47,297,541,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "인벤티지랩",
        "frst_acqs_de": "2020.04.28",
        "invstmnt_purps": "기술성투자",
        "frst_acqs_amount": "999,995,000",
        "bsis_blce_qy": "83,326",
        "bsis_blce_qota_rt": "0.82",
        "bsis_blce_acntbk_amount": "1,774,843,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "891,588,000",
        "trmend_blce_qy": "83,326",
        "trmend_blce_qota_rt": "0.78",
        "trmend_blce_acntbk_amount": "2,666,431,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "72,253,326,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-16,996,522,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "Daewoong Pharma Philippines Incorporated",
        "frst_acqs_de": "2007.04.12",
        "invstmnt_purps": "경영참여",
        "frst_acqs_amount": "260,539,000",
        "bsis_blce_qy": "-",
        "bsis_blce_qota_rt": "100",
        "bsis_blce_acntbk_amount": "260,539,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "-",
        "trmend_blce_qota_rt": "100",
        "trmend_blce_acntbk_amount": "260,539,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "3,857,292,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "696,899,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "(주)입셀",
        "frst_acqs_de": "2020.09.09",
        "invstmnt_purps": "기술성투자",
        "frst_acqs_amount": "2,000,002,000",
        "bsis_blce_qy": "16,144",
        "bsis_blce_qota_rt": "9.09",
        "bsis_blce_acntbk_amount": "4,999,854,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "16,144",
        "trmend_blce_qota_rt": "9.09",
        "trmend_blce_acntbk_amount": "4,999,854,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "6,100,802,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-7,190,910,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "데일리 임파워링 바이오 헬스케어 펀드4호",
        "frst_acqs_de": "2020.09.23",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "1,000,000,000",
        "bsis_blce_qy": "1,000",
        "bsis_blce_qota_rt": "6.83",
        "bsis_blce_acntbk_amount": "798,404,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-68,259,000",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "1,000",
        "trmend_blce_qota_rt": "6.83",
        "trmend_blce_acntbk_amount": "730,145,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "7,738,953,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-1,196,411,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "유안타 퀀텀점프 3호 투자조합",
        "frst_acqs_de": "2021.09.10",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "1,000",
        "bsis_blce_qota_rt": "14.29",
        "bsis_blce_acntbk_amount": "1,000,000,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "1,000",
        "trmend_blce_qota_rt": "14.29",
        "trmend_blce_acntbk_amount": "1,000,000,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "6,526,765,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-145,055,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "(주)티온랩테라퓨틱스",
        "frst_acqs_de": "2021.07.21",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "119,012",
        "bsis_blce_qota_rt": "14.78",
        "bsis_blce_acntbk_amount": "1,239,000,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "119,012",
        "trmend_blce_qota_rt": "14.78",
        "trmend_blce_acntbk_amount": "1,239,000,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "1,415,990,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-287,390,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "서울의료정보연구소",
        "frst_acqs_de": "2020.12.11",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "200,063,000",
        "bsis_blce_qy": "1,067",
        "bsis_blce_qota_rt": "6.08",
        "bsis_blce_acntbk_amount": "200,063,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "1,067",
        "trmend_blce_qota_rt": "6.08",
        "trmend_blce_acntbk_amount": "200,063,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "1,025,506,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-109,766,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "Nurron Pharmaceuticals, INC.",
        "frst_acqs_de": "2021.09.10",
        "invstmnt_purps": "공동연구추진",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "58,343",
        "bsis_blce_qota_rt": "2.00",
        "bsis_blce_acntbk_amount": "570,549,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "58,343",
        "trmend_blce_qota_rt": "2.00",
        "trmend_blce_acntbk_amount": "570,549,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "6,717,196,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-2,256,041,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "Neurogastrx",
        "frst_acqs_de": "2021.06.18",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "4,782,095",
        "bsis_blce_qota_rt": "2.30",
        "bsis_blce_acntbk_amount": "285,061,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "4,782,095",
        "trmend_blce_qota_rt": "2.30",
        "trmend_blce_acntbk_amount": "285,061,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "11,351,922,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-15,069,746,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "온코크로스",
        "frst_acqs_de": "2021.04.01",
        "invstmnt_purps": "공동연구추진",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "79,284",
        "bsis_blce_qota_rt": "0.67",
        "bsis_blce_acntbk_amount": "502,661,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "418,620,000",
        "trmend_blce_qy": "79,284",
        "trmend_blce_qota_rt": "0.67",
        "trmend_blce_acntbk_amount": "921,281,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "21,841,674,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-6,438,875,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "넥스아이",
        "frst_acqs_de": "2021.12.08",
        "invstmnt_purps": "공동연구추진",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "11,705",
        "bsis_blce_qota_rt": "2.70",
        "bsis_blce_acntbk_amount": "999,958,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "11,705",
        "trmend_blce_qota_rt": "2.70",
        "trmend_blce_acntbk_amount": "999,958,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "14,531,329,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-9,108,033,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "씨어스테크놀로지",
        "frst_acqs_de": "2021.12.22",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "331,360",
        "bsis_blce_qota_rt": "2.64",
        "bsis_blce_acntbk_amount": "3,482,594,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "4,735,134,000",
        "trmend_blce_qy": "331,360",
        "trmend_blce_qota_rt": "2.63",
        "trmend_blce_acntbk_amount": "8,217,728,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "28,083,739,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-8,871,453,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "Daewoong Pharmaceutical (Thailand) Company Limited",
        "frst_acqs_de": "2007.08.22",
        "invstmnt_purps": "경영참여",
        "frst_acqs_amount": "205,389,000",
        "bsis_blce_qy": "-",
        "bsis_blce_qota_rt": "100",
        "bsis_blce_acntbk_amount": "205,389,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "-",
        "trmend_blce_qota_rt": "100",
        "trmend_blce_acntbk_amount": "205,389,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "1,850,169,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "182,757,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "미래에셋-현대중공업 신성장투자조합1호",
        "frst_acqs_de": "2021.11.01",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "1,200",
        "bsis_blce_qota_rt": "5.97",
        "bsis_blce_acntbk_amount": "1,200,000,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "1,200",
        "trmend_blce_qota_rt": "5.97",
        "trmend_blce_acntbk_amount": "1,200,000,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "18,220,992,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-555,851,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "에버그린투자파트너스4호펀드",
        "frst_acqs_de": "2021.11.17",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "1,000",
        "bsis_blce_qota_rt": "2.32",
        "bsis_blce_acntbk_amount": "1,000,000,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "1,000",
        "trmend_blce_qota_rt": "2.32",
        "trmend_blce_acntbk_amount": "1,000,000,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "38,419,602,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-2,156,150,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "브이원바이오",
        "frst_acqs_de": "2021.11.30",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "21,667",
        "bsis_blce_qota_rt": "8.86",
        "bsis_blce_acntbk_amount": "390,006,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "21,667",
        "trmend_blce_qota_rt": "8.86",
        "trmend_blce_acntbk_amount": "390,006,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "147,153,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-192,934,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "엑소스템텍",
        "frst_acqs_de": "2021.12.30",
        "invstmnt_purps": "공동연구추진",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "38,865",
        "bsis_blce_qota_rt": "1.40",
        "bsis_blce_acntbk_amount": "999,996,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "38,865",
        "trmend_blce_qota_rt": "1.40",
        "trmend_blce_acntbk_amount": "999,996,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "2,810,325,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-1,579,714,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "베어리버(주5)",
        "frst_acqs_de": "2022.03.31",
        "invstmnt_purps": "일반참여",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "59,520",
        "bsis_blce_qota_rt": "0.58",
        "bsis_blce_acntbk_amount": "297,600,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "59,520",
        "trmend_blce_qota_rt": "0.58",
        "trmend_blce_acntbk_amount": "297,600,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "113,588,992,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "3,964,445,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "핀테라퓨틱스",
        "frst_acqs_de": "2022.02.17",
        "invstmnt_purps": "공동연구추진",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "82,277",
        "bsis_blce_qota_rt": "0.92",
        "bsis_blce_acntbk_amount": "999,982,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "82,277",
        "trmend_blce_qota_rt": "0.92",
        "trmend_blce_acntbk_amount": "999,982,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "16,458,395,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-24,971,400,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "디시젠",
        "frst_acqs_de": "2022.04.22",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "256",
        "bsis_blce_qota_rt": "1.54",
        "bsis_blce_acntbk_amount": "1,001,351,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "256",
        "trmend_blce_qota_rt": "1.54",
        "trmend_blce_acntbk_amount": "1,001,351,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "4,080,832,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-3,489,922,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "시너지에이아이",
        "frst_acqs_de": "2022.04.29",
        "invstmnt_purps": "공동연구추진",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "7,000",
        "bsis_blce_qota_rt": "2.94",
        "bsis_blce_acntbk_amount": "499,996,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "7,000",
        "trmend_blce_qota_rt": "2.94",
        "trmend_blce_acntbk_amount": "499,996,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "838,326,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-918,251,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "메디아이오티",
        "frst_acqs_de": "2022.05.13",
        "invstmnt_purps": "공동연구추진",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "629",
        "bsis_blce_qota_rt": "3.50",
        "bsis_blce_acntbk_amount": "199,709,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "629",
        "trmend_blce_qota_rt": "3.50",
        "trmend_blce_acntbk_amount": "199,709,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "230,229,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-290,962,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "켈스",
        "frst_acqs_de": "2022.10.05",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "92,592",
        "bsis_blce_qota_rt": "2.24",
        "bsis_blce_acntbk_amount": "999,993,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "92,592",
        "trmend_blce_qota_rt": "2.24",
        "trmend_blce_acntbk_amount": "999,993,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "9,267,795,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-1,637,029,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "PT Daewoong Group Indonesia(주2)",
        "frst_acqs_de": "2006.04.01",
        "invstmnt_purps": "경영참여",
        "frst_acqs_amount": "7,812,111,000",
        "bsis_blce_qy": "40,102,161",
        "bsis_blce_qota_rt": "100",
        "bsis_blce_acntbk_amount": "35,938,088,000",
        "incrs_dcrs_acqs_dsps_qy": "28,741,329",
        "incrs_dcrs_acqs_dsps_amount": "24,621,001,000",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "68,843,490",
        "trmend_blce_qota_rt": "100",
        "trmend_blce_acntbk_amount": "60,559,089,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "37,367,072,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "382,318,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "차세대 지역 뉴딜&바이오투자조합",
        "frst_acqs_de": "2022.10.28",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "2,000",
        "bsis_blce_qota_rt": "10.00",
        "bsis_blce_acntbk_amount": "2,000,000,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "2,000",
        "trmend_blce_qota_rt": "10.00",
        "trmend_blce_acntbk_amount": "2,000,000,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "18,995,376,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-474,948,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "셀타스퀘어",
        "frst_acqs_de": "2022.11.14",
        "invstmnt_purps": "공동연구추진",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "20,000",
        "bsis_blce_qota_rt": "4.76",
        "bsis_blce_acntbk_amount": "400,000,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "20,000",
        "trmend_blce_qota_rt": "2.82",
        "trmend_blce_acntbk_amount": "400,000,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "7,307,660,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-1,659,928,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "에피바이오텍",
        "frst_acqs_de": "2022.12.22",
        "invstmnt_purps": "공동연구추진",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "78,947",
        "bsis_blce_qota_rt": "2.62",
        "bsis_blce_acntbk_amount": "1,499,993,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "78,947",
        "trmend_blce_qota_rt": "2.52",
        "trmend_blce_acntbk_amount": "1,499,993,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "2,805,954,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-1,726,142,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "이모티브",
        "frst_acqs_de": "2022.12.26",
        "invstmnt_purps": "공동연구추진",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "685",
        "bsis_blce_qota_rt": "1.04",
        "bsis_blce_acntbk_amount": "159,810,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "685",
        "trmend_blce_qota_rt": "1.04",
        "trmend_blce_acntbk_amount": "159,810,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "2,476,908,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-706,555,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "휴먼스케이프",
        "frst_acqs_de": "2022.10.21",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "2,799",
        "bsis_blce_qota_rt": "1.53",
        "bsis_blce_acntbk_amount": "1,999,986,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "2,799",
        "trmend_blce_qota_rt": "1.53",
        "trmend_blce_acntbk_amount": "1,999,986,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "19,180,695,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-13,373,044,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "PT Selatox Bio Pharma",
        "frst_acqs_de": "2022.12.28",
        "invstmnt_purps": "경영참여",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "54,717",
        "bsis_blce_qota_rt": "99.36",
        "bsis_blce_acntbk_amount": "47,041,639,000",
        "incrs_dcrs_acqs_dsps_qy": "23,700",
        "incrs_dcrs_acqs_dsps_amount": "20,121,300,000",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "78,417",
        "trmend_blce_qota_rt": "99.55",
        "trmend_blce_acntbk_amount": "67,162,939,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "125,368,670,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-2,235,633,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "바이옴에이츠",
        "frst_acqs_de": "2023.03.22",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "901",
        "bsis_blce_qota_rt": "3.19",
        "bsis_blce_acntbk_amount": "300,033,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "901",
        "trmend_blce_qota_rt": "3.17",
        "trmend_blce_acntbk_amount": "300,033,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "902,061,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-971,564,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "Alloplex",
        "frst_acqs_de": "2023.01.27",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "9,794",
        "bsis_blce_qota_rt": "0.27",
        "bsis_blce_acntbk_amount": "827,338,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "9,794",
        "trmend_blce_qota_rt": "0.27",
        "trmend_blce_acntbk_amount": "827,338,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "3,249,858,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-3,806,913,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "VITALLI BIO, INC",
        "frst_acqs_de": "2023.05.30",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "2,098,132",
        "bsis_blce_qota_rt": "16.67",
        "bsis_blce_acntbk_amount": "-",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "2,098,132",
        "trmend_blce_qota_rt": "16.67",
        "trmend_blce_acntbk_amount": "-",
        "recent_bsns_year_fnnr_sttus_tot_assets": "2,115,833,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-17,706,642,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "AEON Biopharma, Inc.",
        "frst_acqs_de": "2023.07.22",
        "invstmnt_purps": "공동연구추진",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "2,400,000",
        "bsis_blce_qota_rt": "6.00",
        "bsis_blce_acntbk_amount": "1,905,120,000",
        "incrs_dcrs_acqs_dsps_qy": "-2,366,666",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "33,334",
        "trmend_blce_qota_rt": "0.29",
        "trmend_blce_acntbk_amount": "1,905,120,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "4,619,596,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "217,744,392,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "Daewoong Pharmaceutical Hongkong PVT., Limited",
        "frst_acqs_de": "2013.08.05",
        "invstmnt_purps": "경영참여",
        "frst_acqs_amount": "17,660,725,000",
        "bsis_blce_qy": "269,255,424",
        "bsis_blce_qota_rt": "89.83",
        "bsis_blce_acntbk_amount": "37,184,429,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "269,255,424",
        "trmend_blce_qota_rt": "89.83",
        "trmend_blce_acntbk_amount": "37,184,429,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "56,559,220,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-20,141,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "라이플렉스 사이언스",
        "frst_acqs_de": "2023.10.18",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "209,938",
        "bsis_blce_qota_rt": "5.17",
        "bsis_blce_acntbk_amount": "300,001,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "209,938",
        "trmend_blce_qota_rt": "5.17",
        "trmend_blce_acntbk_amount": "300,001,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "662,203,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-304,945,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "뉴다이브",
        "frst_acqs_de": "2023.11.13",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "99,999,000",
        "bsis_blce_qy": "898",
        "bsis_blce_qota_rt": "3.59",
        "bsis_blce_acntbk_amount": "299,859,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "898",
        "trmend_blce_qota_rt": "3.59",
        "trmend_blce_acntbk_amount": "299,859,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "2,060,598,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "4,860,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "살루스케어",
        "frst_acqs_de": "2023.12.27",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "5,250",
        "bsis_blce_qota_rt": "4.76",
        "bsis_blce_acntbk_amount": "4,999,995,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "5,250",
        "trmend_blce_qota_rt": "4.76",
        "trmend_blce_acntbk_amount": "4,999,995,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "7,634,786,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "668,234,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "엠디스테이지",
        "frst_acqs_de": "2024.09.30",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "3,704",
        "bsis_blce_qota_rt": "3.33",
        "bsis_blce_acntbk_amount": "100,008,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "3,704",
        "trmend_blce_qota_rt": "3.33",
        "trmend_blce_acntbk_amount": "100,008,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "299,243,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-50,899,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "실비아헬스케어",
        "frst_acqs_de": "2024.12.18",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "625",
        "bsis_blce_qota_rt": "4.77",
        "bsis_blce_acntbk_amount": "1,001,362,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "625",
        "trmend_blce_qota_rt": "4.77",
        "trmend_blce_acntbk_amount": "1,001,362,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "1,636,990,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-703,078,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "대웅인베스트먼트 바이오투자조합 1호",
        "frst_acqs_de": "2023.07.19",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "-",
        "bsis_blce_qota_rt": "10.00",
        "bsis_blce_acntbk_amount": "800,000,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "-",
        "trmend_blce_qota_rt": "10.00",
        "trmend_blce_acntbk_amount": "800,000,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "7,437,050,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-488,320,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "Freemind Investments L.P. Series 2",
        "frst_acqs_de": "2023.06.26",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "-",
        "bsis_blce_qota_rt": "49.50",
        "bsis_blce_acntbk_amount": "660,800,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "-",
        "trmend_blce_qota_rt": "49.50",
        "trmend_blce_acntbk_amount": "660,800,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "1,484,700,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "(주)대웅이엔지",
        "frst_acqs_de": "2023.07.14",
        "invstmnt_purps": "경영참여",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "-",
        "bsis_blce_qota_rt": "100",
        "bsis_blce_acntbk_amount": "479,951,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "-",
        "trmend_blce_qota_rt": "100",
        "trmend_blce_acntbk_amount": "479,951,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "5,481,949,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-871,736,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "한국제약협동조합",
        "frst_acqs_de": "2013.01.18",
        "invstmnt_purps": "일반참여",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "-",
        "bsis_blce_qota_rt": "-",
        "bsis_blce_acntbk_amount": "12,600,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "-",
        "trmend_blce_qota_rt": "-",
        "trmend_blce_acntbk_amount": "12,600,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "4,762,199,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "681,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "Turn Biotechnologies, Inc.",
        "frst_acqs_de": "2023.08.22",
        "invstmnt_purps": "공동연구추진",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "733,036",
        "bsis_blce_qota_rt": "0.89",
        "bsis_blce_acntbk_amount": "824,443,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "733,036",
        "trmend_blce_qota_rt": "0.89",
        "trmend_blce_acntbk_amount": "824,443,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "4,873,147,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-16,269,575,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "북경대웅위업의약과기유한공사",
        "frst_acqs_de": "2007.08.16",
        "invstmnt_purps": "경영참여",
        "frst_acqs_amount": "9,152,033,000",
        "bsis_blce_qy": "-",
        "bsis_blce_qota_rt": "100",
        "bsis_blce_acntbk_amount": "5,827,683,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "-",
        "trmend_blce_qota_rt": "100",
        "trmend_blce_acntbk_amount": "5,827,683,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "4,206,863,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "378,499,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "KAIGENE ",
        "frst_acqs_de": "2025.05.02",
        "invstmnt_purps": "공동연구추진",
        "frst_acqs_amount": "2,158,950,000",
        "bsis_blce_qy": "-",
        "bsis_blce_qota_rt": "-",
        "bsis_blce_acntbk_amount": "-",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "2,158,950,000",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "-",
        "trmend_blce_qota_rt": "-",
        "trmend_blce_acntbk_amount": "2,158,950,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "17,127,529,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-6,231,805,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "메디컬에이아이",
        "frst_acqs_de": "2025.05.21",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "3,000,000,000",
        "bsis_blce_qy": "-",
        "bsis_blce_qota_rt": "-",
        "bsis_blce_acntbk_amount": "-",
        "incrs_dcrs_acqs_dsps_qy": "600,000",
        "incrs_dcrs_acqs_dsps_amount": "3,000,000,000",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "600,000",
        "trmend_blce_qota_rt": "4.76",
        "trmend_blce_acntbk_amount": "3,000,000,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "13,406,855,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-6,460,519,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "뷰브레인헬스케어",
        "frst_acqs_de": "2023.10.06",
        "invstmnt_purps": "공동연구추진",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "1,629",
        "bsis_blce_qota_rt": "4.61",
        "bsis_blce_acntbk_amount": "999,554,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "1,629",
        "trmend_blce_qota_rt": "4.57",
        "trmend_blce_acntbk_amount": "999,554,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "4,048,059,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-2,261,519,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "(주)바이오시네틱스",
        "frst_acqs_de": "2013.05.19",
        "invstmnt_purps": "공동연구추진",
        "frst_acqs_amount": "2,000,000,000",
        "bsis_blce_qy": "645,000",
        "bsis_blce_qota_rt": "17.96",
        "bsis_blce_acntbk_amount": "-",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "645,000",
        "trmend_blce_qota_rt": "17.96",
        "trmend_blce_acntbk_amount": "-",
        "recent_bsns_year_fnnr_sttus_tot_assets": "748,465,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "121,361,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "(주)이피피미디어",
        "frst_acqs_de": "2008.01.25",
        "invstmnt_purps": "사업목적",
        "frst_acqs_amount": "1,000,000,000",
        "bsis_blce_qy": "100,000",
        "bsis_blce_qota_rt": "20.00",
        "bsis_blce_acntbk_amount": "-",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "-",
        "incrs_dcrs_evl_lstmn": "-",
        "trmend_blce_qy": "100,000",
        "trmend_blce_qota_rt": "20.00",
        "trmend_blce_acntbk_amount": "-",
        "recent_bsns_year_fnnr_sttus_tot_assets": "6,410,395,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "58,889,000",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "inv_prm": "합계",
        "frst_acqs_de": "-",
        "invstmnt_purps": "-",
        "frst_acqs_amount": "-",
        "bsis_blce_qy": "-",
        "bsis_blce_qota_rt": "-",
        "bsis_blce_acntbk_amount": "390,219,559,000",
        "incrs_dcrs_acqs_dsps_qy": "-",
        "incrs_dcrs_acqs_dsps_amount": "49,832,992,000",
        "incrs_dcrs_evl_lstmn": "-5,510,396,000",
        "trmend_blce_qy": "-",
        "trmend_blce_qota_rt": "-",
        "trmend_blce_acntbk_amount": "434,542,155,000",
        "recent_bsns_year_fnnr_sttus_tot_assets": "2,413,073,633,000",
        "recent_bsns_year_fnnr_sttus_thstrm_ntpf": "-207,767,134,000",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_13": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "보통주",
        "isu_stock_totqy": "32,000,000",
        "now_to_isu_stock_totqy": "11,586,575",
        "now_to_dcrs_stock_totqy": "-",
        "redc": "-",
        "profit_incnr": "-",
        "rdmstk_repy": "-",
        "etc": "-",
        "istc_totqy": "11,586,575",
        "tesstk_co": "80,305",
        "distb_stock_co": "11,506,270",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "우선주",
        "isu_stock_totqy": "-",
        "now_to_isu_stock_totqy": "-",
        "now_to_dcrs_stock_totqy": "-",
        "redc": "-",
        "profit_incnr": "-",
        "rdmstk_repy": "-",
        "etc": "-",
        "istc_totqy": "-",
        "tesstk_co": "-",
        "distb_stock_co": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "합계",
        "isu_stock_totqy": "32,000,000",
        "now_to_isu_stock_totqy": "11,586,575",
        "now_to_dcrs_stock_totqy": "-",
        "redc": "-",
        "profit_incnr": "-",
        "rdmstk_repy": "-",
        "etc": "-",
        "istc_totqy": "11,586,575",
        "tesstk_co": "80,305",
        "distb_stock_co": "11,506,270",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "비고",
        "isu_stock_totqy": "-",
        "now_to_isu_stock_totqy": "-",
        "now_to_dcrs_stock_totqy": "-",
        "redc": "-",
        "profit_incnr": "-",
        "rdmstk_repy": "-",
        "etc": "-",
        "istc_totqy": "-",
        "tesstk_co": "-",
        "distb_stock_co": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_14": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "isu_cmpny": "(주)대웅제약",
        "scrits_knd_nm": "회사채",
        "isu_mth_nm": "공모",
        "isu_de": "2024.04.09",
        "facvalu_totamt": "91,000,000,000",
        "intrt": "4.037%",
        "evl_grad_instt": "A+\n(한기평, NICE)",
        "mtd": "2026.04.09",
        "repy_at": "미상환",
        "mngt_cmpny": "KB증권\n미래에셋증권\n한국투자증권",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "isu_cmpny": "(주)대웅제약",
        "scrits_knd_nm": "회사채",
        "isu_mth_nm": "공모",
        "isu_de": "2024.04.09",
        "facvalu_totamt": "104,000,000,000",
        "intrt": "4.098%",
        "evl_grad_instt": "A+\n(한기평, NICE)",
        "mtd": "2027.04.09",
        "repy_at": "미상환",
        "mngt_cmpny": "KB증권\n미래에셋증권\n한국투자증권",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "isu_cmpny": "(주)대웅제약",
        "scrits_knd_nm": "회사채",
        "isu_mth_nm": "공모",
        "isu_de": "2025.04.29",
        "facvalu_totamt": "50,000,000,000",
        "intrt": "2.915%",
        "evl_grad_instt": "A+\n(한기평, NICE)",
        "mtd": "2027.04.29",
        "repy_at": "미상환",
        "mngt_cmpny": "NH투자증권\nKB증권\n한국투자증권",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "isu_cmpny": "(주)대웅제약",
        "scrits_knd_nm": "회사채",
        "isu_mth_nm": "공모",
        "isu_de": "2025.04.29",
        "facvalu_totamt": "90,000,000,000",
        "intrt": "3.001%",
        "evl_grad_instt": "A+\n(한기평, NICE)",
        "mtd": "2028.04.28",
        "repy_at": "미상환",
        "mngt_cmpny": "NH투자증권\nKB증권\n한국투자증권",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "isu_cmpny": "합 계",
        "scrits_knd_nm": "-",
        "isu_mth_nm": "-",
        "isu_de": "-",
        "facvalu_totamt": "335,000,000,000",
        "intrt": "-",
        "evl_grad_instt": "-",
        "mtd": "-",
        "repy_at": "-",
        "mngt_cmpny": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_15": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "sm": "-",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "공모",
        "de10_below": "-",
        "de10_excess_de30_below": "-",
        "de30_excess_de90_below": "-",
        "de90_excess_de180_below": "-",
        "de180_excess_yy1_below": "-",
        "yy1_excess_yy2_below": "-",
        "yy2_excess_yy3_below": "-",
        "yy3_excess": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "sm": "-",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "사모",
        "de10_below": "-",
        "de10_excess_de30_below": "-",
        "de30_excess_de90_below": "-",
        "de90_excess_de180_below": "-",
        "de180_excess_yy1_below": "-",
        "yy1_excess_yy2_below": "-",
        "yy2_excess_yy3_below": "-",
        "yy3_excess": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "sm": "-",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "합계",
        "de10_below": "-",
        "de10_excess_de30_below": "-",
        "de30_excess_de90_below": "-",
        "de90_excess_de180_below": "-",
        "de180_excess_yy1_below": "-",
        "yy1_excess_yy2_below": "-",
        "yy2_excess_yy3_below": "-",
        "yy3_excess": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_16": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "sm": "-",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "공모",
        "de10_below": "-",
        "de10_excess_de30_below": "-",
        "de30_excess_de90_below": "-",
        "de90_excess_de180_below": "-",
        "de180_excess_yy1_below": "-",
        "isu_lmt": "-",
        "remndr_lmt": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "sm": "-",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "사모",
        "de10_below": "-",
        "de10_excess_de30_below": "-",
        "de30_excess_de90_below": "-",
        "de90_excess_de180_below": "-",
        "de180_excess_yy1_below": "-",
        "isu_lmt": "-",
        "remndr_lmt": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "sm": "-",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "합계",
        "de10_below": "-",
        "de10_excess_de30_below": "-",
        "de30_excess_de90_below": "-",
        "de90_excess_de180_below": "-",
        "de180_excess_yy1_below": "-",
        "isu_lmt": "-",
        "remndr_lmt": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_17": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "sm": "335,000,000,000",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "공모",
        "yy1_excess_yy2_below": "154,000,000,000",
        "yy2_excess_yy3_below": "90,000,000,000",
        "yy1_below": "91,000,000,000",
        "yy3_excess_yy4_below": "-",
        "yy4_excess_yy5_below": "-",
        "yy5_excess_yy10_below": "-",
        "yy10_excess": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "sm": "-",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "사모",
        "yy1_excess_yy2_below": "-",
        "yy2_excess_yy3_below": "-",
        "yy1_below": "-",
        "yy3_excess_yy4_below": "-",
        "yy4_excess_yy5_below": "-",
        "yy5_excess_yy10_below": "-",
        "yy10_excess": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "sm": "335,000,000,000",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "합계",
        "yy1_excess_yy2_below": "154,000,000,000",
        "yy2_excess_yy3_below": "90,000,000,000",
        "yy1_below": "91,000,000,000",
        "yy3_excess_yy4_below": "-",
        "yy4_excess_yy5_below": "-",
        "yy5_excess_yy10_below": "-",
        "yy10_excess": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_18": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "sm": "-",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "공모",
        "yy1_below": "-",
        "yy5_excess_yy10_below": "-",
        "yy1_excess_yy5_below": "-",
        "yy10_excess_yy15_below": "-",
        "yy15_excess_yy20_below": "-",
        "yy20_excess_yy30_below": "-",
        "yy30_excess": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "sm": "-",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "사모",
        "yy1_below": "-",
        "yy5_excess_yy10_below": "-",
        "yy1_excess_yy5_below": "-",
        "yy10_excess_yy15_below": "-",
        "yy15_excess_yy20_below": "-",
        "yy20_excess_yy30_below": "-",
        "yy30_excess": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "sm": "-",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "합계",
        "yy1_below": "-",
        "yy5_excess_yy10_below": "-",
        "yy1_excess_yy5_below": "-",
        "yy10_excess_yy15_below": "-",
        "yy15_excess_yy20_below": "-",
        "yy20_excess_yy30_below": "-",
        "yy30_excess": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_19": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "sm": "-",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "공모",
        "yy1_excess_yy2_below": "-",
        "yy2_excess_yy3_below": "-",
        "yy1_below": "-",
        "yy3_excess_yy4_below": "-",
        "yy4_excess_yy5_below": "-",
        "yy5_excess_yy10_below": "-",
        "yy20_excess_yy30_below": "-",
        "yy30_excess": "-",
        "yy10_excess_yy20_below": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "sm": "-",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "사모",
        "yy1_excess_yy2_below": "-",
        "yy2_excess_yy3_below": "-",
        "yy1_below": "-",
        "yy3_excess_yy4_below": "-",
        "yy4_excess_yy5_below": "-",
        "yy5_excess_yy10_below": "-",
        "yy20_excess_yy30_below": "-",
        "yy30_excess": "-",
        "yy10_excess_yy20_below": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "sm": "-",
        "remndr_exprtn1": "미상환잔액",
        "remndr_exprtn2": "합계",
        "yy1_excess_yy2_below": "-",
        "yy2_excess_yy3_below": "-",
        "yy1_below": "-",
        "yy3_excess_yy4_below": "-",
        "yy4_excess_yy5_below": "-",
        "yy5_excess_yy10_below": "-",
        "yy20_excess_yy30_below": "-",
        "yy30_excess": "-",
        "yy10_excess_yy20_below": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_20": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "bsns_year": "제24기 반기\n(당반기)",
        "adtor": "한영회계법인",
        "adt_reprt_spcmnt_matter": "-",
        "emphs_matter": "해당사항 없음",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "bsns_year": "제24기 반기\n(당반기)",
        "adtor": "한영회계법인",
        "adt_reprt_spcmnt_matter": "-",
        "emphs_matter": "해당사항 없음",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "bsns_year": "제23기\n(전기)",
        "adtor": "삼정회계법인",
        "adt_opinion": "적정의견",
        "adt_reprt_spcmnt_matter": "-",
        "emphs_matter": "해당사항 없음",
        "core_adt_matter": "내부적으로 창출한 \n개발비 손상검사",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "bsns_year": "제23기\n(전기)",
        "adtor": "삼정회계법인",
        "adt_opinion": "적정의견",
        "adt_reprt_spcmnt_matter": "-",
        "emphs_matter": "해당사항 없음",
        "core_adt_matter": "내부적으로 창출한 \n개발비 손상검사",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "bsns_year": "제22기\n(전전기)",
        "adtor": "삼정회계법인",
        "adt_opinion": "적정의견",
        "adt_reprt_spcmnt_matter": "-",
        "emphs_matter": "해당사항 없음",
        "core_adt_matter": "내부적으로 창출한 \n개발비 손상검사",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "bsns_year": "제22기\n(전전기)",
        "adtor": "삼정회계법인",
        "adt_opinion": "적정의견",
        "adt_reprt_spcmnt_matter": "-",
        "emphs_matter": "해당사항 없음",
        "core_adt_matter": "내부적으로 창출한 \n개발비 손상검사",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_21": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "bsns_year": "제24기 반기\n(당반기)",
        "adtor": "한영회계법인",
        "cn": "분ㆍ반기 재무제표 검토\n별도 및 연결 재무제표에 대한 감사\n내부회계관리제도 감사",
        "mendng": "-",
        "tot_reqre_time": "-",
        "adt_cntrct_dtls_mendng": "390",
        "adt_cntrct_dtls_time": "4,700",
        "real_exc_dtls_mendng": "195",
        "real_exc_dtls_time": "1,619",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "bsns_year": "제23기 (전기)",
        "adtor": "삼정회계법인",
        "cn": "분ㆍ반기 재무제표 검토\n별도 및 연결 재무제표에 대한 감사\n내부회계관리제도 감사",
        "mendng": "-",
        "tot_reqre_time": "-",
        "adt_cntrct_dtls_mendng": "605",
        "adt_cntrct_dtls_time": "5,040",
        "real_exc_dtls_mendng": "605",
        "real_exc_dtls_time": "5,220",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "bsns_year": "제22기 (전전기)",
        "adtor": "삼정회계법인",
        "cn": "분ㆍ반기 재무제표 검토\n별도 및 연결 재무제표에 대한 감사\n내부회계관리제도 감사",
        "mendng": "-",
        "tot_reqre_time": "-",
        "adt_cntrct_dtls_mendng": "580",
        "adt_cntrct_dtls_time": "4,830",
        "real_exc_dtls_mendng": "580",
        "real_exc_dtls_time": "4,832",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_22": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "bsns_year": "제24기 반기 (당반기)",
        "cntrct_cncls_de": "-",
        "servc_cn": "-",
        "servc_exc_pd": "-",
        "servc_mendng": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "bsns_year": "제23기 (전기)",
        "cntrct_cncls_de": "-",
        "servc_cn": "-",
        "servc_exc_pd": "-",
        "servc_mendng": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "bsns_year": "제22기 (전전기)",
        "cntrct_cncls_de": "-",
        "servc_cn": "-",
        "servc_exc_pd": "-",
        "servc_mendng": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_23": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "drctr_co": "5",
        "otcmp_drctr_co": "2",
        "apnt": "1",
        "rlsofc": "-",
        "mdstrm_resig": "1",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_24": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "미등기임원",
        "fyer_salary_totamt": "1,019,000,000",
        "jan_salary_am": "127,000,000",
        "nmpr": "8",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_25": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "등기이사",
        "nmpr": "5",
        "gmtsck_confm_amount": "3,000,000,000",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "감사",
        "nmpr": "1",
        "gmtsck_confm_amount": "200,000,000",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_26": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "등기이사(사외이사, 감사위원회 위원 제외)",
        "nmpr": "3",
        "pymnt_totamt": "1,103,000,000",
        "psn1_avrg_pymntamt": "368,000,000",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "사외이사(감사위원회 위원 제외)",
        "nmpr": "2",
        "pymnt_totamt": "45,000,000",
        "psn1_avrg_pymntamt": "22,000,000",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "감사위원회 위원",
        "nmpr": "-",
        "pymnt_totamt": "-",
        "psn1_avrg_pymntamt": "-",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se": "감사",
        "nmpr": "1",
        "pymnt_totamt": "30,000,000",
        "psn1_avrg_pymntamt": "30,000,000",
        "rm": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_27": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se_nm": "회사채",
        "tm": "제16-1회",
        "pay_de": "2024.04.09",
        "pay_amount": "-",
        "on_dclrt_cptal_use_plan": "-",
        "real_cptal_use_sttus": "-",
        "rs_cptal_use_plan_useprps": "차환자금",
        "rs_cptal_use_plan_prcure_amount": "91,000,000,000",
        "real_cptal_use_dtls_cn": "차환자금",
        "real_cptal_use_dtls_amount": "91,000,000,000",
        "dffrnc_occrrnc_resn": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se_nm": "회사채",
        "tm": "제16-2회",
        "pay_de": "2024.04.09",
        "pay_amount": "-",
        "on_dclrt_cptal_use_plan": "-",
        "real_cptal_use_sttus": "-",
        "rs_cptal_use_plan_useprps": "차환자금",
        "rs_cptal_use_plan_prcure_amount": "69,000,000,000",
        "real_cptal_use_dtls_cn": "차환자금",
        "real_cptal_use_dtls_amount": "69,000,000,000",
        "dffrnc_occrrnc_resn": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se_nm": "회사채",
        "tm": "제16-2회",
        "pay_de": "2024.04.09",
        "pay_amount": "-",
        "on_dclrt_cptal_use_plan": "-",
        "real_cptal_use_sttus": "-",
        "rs_cptal_use_plan_useprps": "시설자금",
        "rs_cptal_use_plan_prcure_amount": "35,000,000,000",
        "real_cptal_use_dtls_cn": "시설자금",
        "real_cptal_use_dtls_amount": "35,000,000,000",
        "dffrnc_occrrnc_resn": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se_nm": "회사채",
        "tm": "제17-1회",
        "pay_de": "2025.04.29",
        "pay_amount": "-",
        "on_dclrt_cptal_use_plan": "-",
        "real_cptal_use_sttus": "-",
        "rs_cptal_use_plan_useprps": "시설자금",
        "rs_cptal_use_plan_prcure_amount": "40,000,000,000",
        "real_cptal_use_dtls_cn": "시설자금",
        "real_cptal_use_dtls_amount": "40,000,000,000",
        "dffrnc_occrrnc_resn": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se_nm": "회사채",
        "tm": "제17-1회",
        "pay_de": "2025.04.29",
        "pay_amount": "-",
        "on_dclrt_cptal_use_plan": "-",
        "real_cptal_use_sttus": "-",
        "rs_cptal_use_plan_useprps": "차환자금",
        "rs_cptal_use_plan_prcure_amount": "10,000,000,000",
        "real_cptal_use_dtls_cn": "차환자금",
        "real_cptal_use_dtls_amount": "10,000,000,000",
        "dffrnc_occrrnc_resn": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se_nm": "회사채",
        "tm": "제17-2회",
        "pay_de": "2025.04.29",
        "pay_amount": "-",
        "on_dclrt_cptal_use_plan": "-",
        "real_cptal_use_sttus": "-",
        "rs_cptal_use_plan_useprps": "운영자금",
        "rs_cptal_use_plan_prcure_amount": "30,000,000,000",
        "real_cptal_use_dtls_cn": "운영자금",
        "real_cptal_use_dtls_amount": "30,000,000,000",
        "dffrnc_occrrnc_resn": "-",
        "stlm_dt": "2025-06-30"
      },
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se_nm": "회사채",
        "tm": "제17-2회",
        "pay_de": "2025.04.29",
        "pay_amount": "-",
        "on_dclrt_cptal_use_plan": "-",
        "real_cptal_use_sttus": "-",
        "rs_cptal_use_plan_useprps": "차환자금",
        "rs_cptal_use_plan_prcure_amount": "60,000,000,000",
        "real_cptal_use_dtls_cn": "차환자금",
        "real_cptal_use_dtls_amount": "60,000,000,000",
        "dffrnc_occrrnc_resn": "-",
        "stlm_dt": "2025-06-30"
      }
    ],
    "api_28": [
      {
        "rcept_no": "20250814004456",
        "corp_cls": "Y",
        "corp_code": "00427483",
        "corp_name": "대웅제약",
        "se_nm": "-",
        "tm": "-",
        "pay_de": "-",
        "pay_amount": "-",
        "real_cptal_use_sttus": "-",
        "real_cptal_use_dtls_cn": "-",
        "real_cptal_use_dtls_amount": "-",
        "dffrnc_occrrnc_resn": "-",
        "cptal_use_plan": "-",
        "mtrpt_cptal_use_plan_useprps": "-",
        "mtrpt_cptal_use_plan_prcure_amount": "-",
        "stlm_dt": "2025-06-30"
      }
    ]
  }
}